An international study has shown that a new injectable drug (benralizumab) successfully targets the receptor of the immune system protein interleukin-5 (IL-5), allowing patients with hard-to-control asthma associated with blood or sputum eosinophils to reduce or discontinue oral steroids while …

Phase III trial shows new drug can help patients with severe asthma reduce oral steroids Read more »

What do Instagram, breastfeeding, a Manitoba-based epidemiologist and an Alberta-based digital technology expert have in common? They all come together in a new research project, with the AllerGen network as the catalyst. At AllerGen’s 2016 Research Conference in Vancouver, BC, …

Virtual breastfeeding communities: a project inspired at AllerGen event Read more »

A study co-authored by AllerGen investigator Dr. Greg Evans, a University of Toronto professor of chemical engineering and director of the Southern Ontario Centre for Atmospheric Aerosol Research (SOCAAR), has found that passengers travelling in diesel-powered commuter GO trains risk …

Study finds GO train riders exposed to high level of diesel exhaust Read more »

AllerGen Research Leader Dr. Jeffrey Brook is Scientific Director and Nominated-Principal Investigator on a new five-year, $4.16 million Operating Grant from the CIHR’s Environments and Health Signature Initiative. The project, CANadian Urban Environmental (CANUE) Health Research Consortium, aims to advance …

AllerGen Research Leader heads major urban health project Read more »